| Authors: |
Rock V; American Brain Tumor Association, Chicago, IL, USA., Ahluwalia MS; Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA., Anthony M; Head for the Cure, Kansas City, MO, USA., Arons D; National Brain Tumor Society, Newton, MA, USA., Arzbaecher J; University of Illinois at Chicago Medical Center, Chicago, IL, USA., Dunbar E; Piedmont Brain Tumor Center, Piedmont Atlanta Hospital, Atlanta, GA, USA., Fraher C; The Brain Tumour Charity, Fleet, UK., Freund M; American Brain Tumor Association, Chicago, IL, USA., Gondi V; Northwestern Medicine Cancer Center Warrenville, Northwestern University Feinberg School of Medicine, Warrenville/Chicago, IL, USA., Khanuja S; American Brain Tumor Association, Chicago, IL, USA., Leach D; National Brain Tumor Society, Newton, MA, USA., Loughan AR; Virginia Commonwealth University, Massey Cancer Center, Mechanicsville, VA, USA., Musella A; Musella Foundation, Hewlitt, NY, USA., Oliver K; The International Brain Tumour Alliance, Tadworth, UK., Paabo K; Brain Tumor Network, Ponte Vedre Beach, FL, USA., Puduvalli VK; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shaffer GD; Southeastern Brain Tumor Foundation, Atlanta, GA, USA., Thomas AA; University of Vermont Medical Center, The University of Vermont Health Network, Burlington, VT, USA., Wallgren K; CERN Foundation, a program of the National Brain Tumor Society, Newton, MA, USA., Wefel JS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yu JS; Cleveland Clinic, Cleveland, OH, USA., Zada G; Keck Medicine of the University of Southern California, Los Angeles, CA, USA., Willmarth N; American Brain Tumor Association, Chicago, IL, USA., DeVitto R; American Brain Tumor Association, Chicago, IL, USA. |
